Orange Book product · Generic (ANDA)
ELTROMBOPAG OLAMINE
ELTROMBOPAG OLAMINE
At a glance
Jan 14, 2026
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 14, 2026
5 mo ago
Today
Pharmaceutical detail
Active ingredient
ELTROMBOPAG OLAMINE
Strength
EQ 12.5MG ACID
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 220250
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ELTROMBOPAG OLAMINE
- 2018PROMACTA KITBrand (NDA)
NDA 207027 · NOVARTIS
- 2011PROMACTABrand (NDA)
NDA 022291 · NOVARTIS
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220660 · BIOCON PHARMA
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220033 · HIKMA
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 219121 · DR REDDYS
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 212884 · AMNEAL
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 219638 · SOMERSET THERAPS LLC
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 216281 · ZYDUS PHARMS
- 2025ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 206788 · HETERO LABS LTD V
- 2024ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 216620 · ANNORA PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
